Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse-Reference-Cited by-同舟云学术

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Published:2019-02-04 Issue:4 Volume:13 Page:1800133
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Hoff Fieke W.¹^ORCID,Hu Chenyue W.²,Qutub Amina A.³,Qiu Yihua⁴,Hornbaker Marisa J.⁴⁵,Bueso‐Ramos Carlos⁶,Abbas Hussein A.⁷,Post Sean M.⁴,Bont Eveline S. J. M.¹,Kornblau Steven M.⁴

Affiliation:

1. Department of Pediatric Oncology/HematologyBeatrix Children's HospitalUniversity Medical Center GroningenUniversity of Groningen Groningen 9713 The Netherlands

2. Department of BioengineeringRice University Houston TX 77030 USA

3. Department of Biomedical EngineeringUniversity of Texas San Antonio San Antonio TX 78429 USA

4. Department of LeukemiaThe University of Texas MD Anderson Cancer Center Houston TX 77030‐4009 USA

5. The University of Texas Graduate School of Biomedical Sciences at Houston Houston TX 77030 USA

6. Department of HematopathologyThe University of Texas MD Anderson Cancer Center Houston TX 77030 USA

7. Hematology and Oncology Fellowship ProgramCancer Medicine DivisionThe University of Texas MD Anderson Cancer Center Houston TX 77030 USA

Funder

Leukemia and Lymphoma Society

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.201800133

Reference30 articles.

1. Gemtuzumab Ozogamicin: Time to Resurrect?

2. Incidence rates of acute promyelocytic leukemia among Hispanics, blacks, Asians, and non-Hispanic whites in the United States

3. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients

4. Acute promyelocytic leukemia: where did we start, where are we now, and the future

5. The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic and phosphoproteomic landscapes of acute myeloid leukemia;Blood;2022-09-29

2. Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission;Frontiers in Genetics;2022-04-12

3. Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets;Blood Cancer Journal;2022-03-17

4. Reverse phase protein arrays in acute leukemia: investigative and methodological challenges;Expert Review of Proteomics;2021-12-02

5. Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective;Expert Review of Proteomics;2020-01-02